Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-03
2007-07-03
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S557000, C514S612000, C514S617000
Reexamination Certificate
active
09452406
ABSTRACT:
Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.
REFERENCES:
patent: 4108855 (1978-08-01), Mago nee Karacsony et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4737580 (1988-04-01), Twardzik et al.
patent: 4774318 (1988-09-01), Marquardt et al.
patent: 5028594 (1991-07-01), Carson
patent: 5079228 (1992-01-01), Cohen et al.
patent: 5155038 (1992-10-01), Eyal et al.
patent: 5190918 (1993-03-01), Deutch et al.
patent: 5190920 (1993-03-01), Eyal et al.
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5202118 (1993-04-01), Gillis et al.
patent: 5212073 (1993-05-01), Rollins et al.
patent: 5248666 (1993-09-01), Twardzik et al.
patent: 5302384 (1994-04-01), Gimbrone, Jr. et al.
patent: 5357041 (1994-10-01), Roberts et al.
patent: 5401651 (1995-03-01), Walz
patent: 5426100 (1995-06-01), Deutch et al.
patent: 5458874 (1995-10-01), Pereira et al.
patent: 5459128 (1995-10-01), Rollins et al.
patent: 5474983 (1995-12-01), Kuna et al.
patent: 5491130 (1996-02-01), Roberts et al.
patent: 5532144 (1996-07-01), Yoshimura et al.
patent: 5545623 (1996-08-01), Matsumori
patent: 5556757 (1996-09-01), Alstyne et al.
patent: 5571713 (1996-11-01), Lyle et al.
patent: 5578714 (1996-11-01), Pogo et al.
patent: 5589458 (1996-12-01), Jameson et al.
patent: 5597578 (1997-01-01), Brown et al.
patent: 5605671 (1997-02-01), Lyle et al.
patent: 5627156 (1997-05-01), Talmadge
patent: 5627265 (1997-05-01), Frazier et al.
patent: 5629327 (1997-05-01), D'Amato
patent: 5645837 (1997-07-01), Jameson et al.
patent: 5646117 (1997-07-01), Matsushima et al.
patent: 5650150 (1997-07-01), Gillies
patent: 5661132 (1997-08-01), Eriksson et al.
patent: 5663294 (1997-09-01), Colman et al.
patent: 5684032 (1997-11-01), Elliott et al.
patent: 5700821 (1997-12-01), Lazo et al.
patent: 5705360 (1998-01-01), Rollins et al.
patent: 5707814 (1998-01-01), Levy et al.
patent: 5707815 (1998-01-01), Charo et al.
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5807482 (1998-09-01), House
patent: 5811449 (1998-09-01), Medford et al.
patent: 5817911 (1998-10-01), Williams et al.
patent: 5824299 (1998-10-01), Luster et al.
patent: 5824551 (1998-10-01), Damme et al.
patent: 5824647 (1998-10-01), Postlethwaite et al.
patent: 5827821 (1998-10-01), Pierschbacher et al.
patent: 5831032 (1998-11-01), Schraufstatter et al.
patent: 5871740 (1999-02-01), Smith
patent: 5877276 (1999-03-01), Talmadge
patent: 5908829 (1999-06-01), Kelly
patent: 5955485 (1999-09-01), De Brabander et al.
patent: 5955492 (1999-09-01), Thompson et al.
patent: 2710246 (1977-09-01), None
patent: 0 281 363 (1988-09-01), None
patent: 0 353 772 (1990-02-01), None
patent: 0 373 994 (1990-06-01), None
patent: 0 807 439 (1997-11-01), None
patent: 0 860 446 (1998-08-01), None
patent: 0860446 (1998-08-01), None
patent: 0905241 (1999-03-01), None
patent: 2 319 252 (1998-05-01), None
patent: 36-14610 (1961-08-01), None
patent: 86/04334 (1986-07-01), None
patent: 06-025288 (1994-02-01), None
patent: 7-67689 (1995-03-01), None
patent: 09255570 (1997-09-01), None
patent: 11124393 (1999-05-01), None
patent: 11130767 (1999-05-01), None
patent: 11130778 (1999-05-01), None
patent: 11130792 (1999-05-01), None
patent: 11137283 (1999-05-01), None
patent: 11137299 (1999-05-01), None
patent: 90/07863 (1990-07-01), None
patent: 91/03491 (1991-03-01), None
patent: 91/08483 (1991-06-01), None
patent: 91/17179 (1991-11-01), None
patent: WO92/14455 (1992-02-01), None
patent: 92/04372 (1992-03-01), None
patent: 92/20372 (1992-11-01), None
patent: 93/10796 (1993-06-01), None
patent: 93/11159 (1993-06-01), None
patent: WO-9310796 (1993-06-01), None
patent: 94/11014 (1994-05-01), None
patent: 94/20512 (1994-09-01), None
patent: 95/05191 (1995-02-01), None
patent: 95/17420 (1995-06-01), None
patent: 95/17421 (1995-06-01), None
patent: 95/20973 (1995-08-01), None
patent: 95/26982 (1995-10-01), None
patent: 96/20722 (1996-07-01), None
patent: 96/22371 (1996-07-01), None
patent: 97/01350 (1997-01-01), None
patent: 97/12615 (1997-04-01), None
patent: 97/19173 (1997-05-01), None
patent: 97/21812 (1997-06-01), None
patent: 97/22698 (1997-06-01), None
patent: 97/24325 (1997-07-01), None
patent: 97/25427 (1997-07-01), None
patent: 97/29192 (1997-08-01), None
patent: 97/31098 (1997-08-01), None
patent: 97/31949 (1997-09-01), None
patent: 97/32019 (1997-09-01), None
patent: 97/32993 (1997-09-01), None
patent: 97/35010 (1997-09-01), None
patent: 97/35982 (1997-10-01), None
patent: 97/44462 (1997-11-01), None
patent: 97/45543 (1997-12-01), None
patent: 98/06703 (1998-02-01), None
patent: 98/09171 (1998-03-01), None
patent: 98/12324 (1998-03-01), None
patent: 98/13495 (1998-04-01), None
patent: 98/23750 (1998-06-01), None
patent: 98/24808 (1998-06-01), None
patent: 98/42354 (1998-10-01), None
patent: WO-9842354 (1998-10-01), None
patent: 98/00535 (1998-12-01), None
patent: 98/54326 (1998-12-01), None
patent: 99/04770 (1999-02-01), None
patent: 99/04791 (1999-02-01), None
patent: 99/05279 (1999-02-01), None
patent: 99/12968 (1999-03-01), None
patent: 99/37617 (1999-07-01), None
patent: 99/37619 (1999-07-01), None
patent: 99/37651 (1999-07-01), None
patent: 99/42461 (1999-08-01), None
patent: 99/42463 (1999-08-01), None
patent: WO-00/00821 (2000-01-01), None
Paul , Fundamental Immunology, third ed., 1993, Raven Press, p. 822-826.
Gong, J., et al., “RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors”,The Journal of Biological Chemistry, 271, 10521-10527 (1996).
“Blocking CCR5 Stops M-tropic HIV Infection”,Biotechnology News, 17, 3, (1997).
“Leukotrine Antagonists Making Their Mark in Asthma”,SCRIP, No. 2376, John Davis, (ed.), 23, (Oct. 7, 1998).
Albini et al., “HIV-1 Tat Protein Mimicry of Chemokines”,Proc. Natl. Acad. Sci. USA, 95, 13153-13158 (1998).
Adkins et al., “Zafirlukast—A Review of its Pharmacology and Therapeutic Potential in the Management of Asthma”,Drugs, 55, 121-144 (1998).
Albanesi et al., “Cetirizine and Hydrocortisone Differentially Regulate ICAM-I Expression and Chemokine Release in Cultured Human Keratinocytes”,Clinical and Experimental Allergy, 28, 101-109 (1998).
Alkhatib et al., “HIV-1 Coreceptor Activity of CCR5 and Its Inhibition by Chemokines: Independence from G Protein Signaling and Importance of Coreceptor Downmodulation”,Virology, 234, 340-348 (1997).
Amann et al., “Urinary Levels of Monocyte Chemo-Attractant Protein-1 Correlate with Tumour Stage and Grade in Patients with Bladder Cancer”,British Journal of Urology, 82, 118-121 (1998).
Arenzana-Seisdedos et al., “HIV Blocked by Chemokine Antagonists”,Nature, 383, 400 (1996).
Auer et al., “Crystallization and Preliminary X-ray Crystallographic Study of Interleukin-8”,FEBS Letters, 265, 30-32 (1990).
Bacon et al., “Activation of Dual T Cell Signaling Pathways by the Chemokine RANTES”,Science, 269, 1727-1730 (1995).
Bacon et al., “Chemokines in Disease Models and Pathogenesis”,Cytokine and Growth Factor Reviews, 9, 167-173 (1998).
Baldwin et al., “Crystal Structure of Interleukin 8: Synbiosis of NMR and Crystallography”,Proc. Natl. Acad. Sci. USA, 88, 502-506 (1991).
Baldwin et al., “Crystallization of Human Interleukin-8”,The Journal of Biological Chemistry, 265, 6851-6853 (1990).
Beck-Schimmer et al., “Hyaluronan Induces Monocyte Chemoattractant Protein-1 Expression in Renal Tubular Epithelial Cells”,Journal of the American Society of Nephrology, 9, 2283-2290 (1988).
Bernstein et al., “A Randomized Phase II Study of BB-10010: a Variant of Human Macrophage Inflammatory Protein-1α for Patients Receiving High-Dose Etoposide and Cyclophosphamide for Malignant Lymphoma and Breast Cancer”,British Journal of Haematology, 99, 888-895 (1997).
Berson et al., “Structure-Function Studies of the HIV-1 Coreceptors”,Seminars in Immunology, 10, 237-248 (1998).
Bodaghi et al., “Chemokine Sequest
Grainger David J.
Tatalick Lauren Marie
Cambridge University Technical Services Ltd.
Hui San-Ming
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Compounds and methods to inhibit or augment an inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods to inhibit or augment an inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods to inhibit or augment an inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3819773